Clozapine Tablets (VA-23-00004594)   3

Background
The Department of Veterans Affairs (VA) and the Department of Defense (DOD) acquire their pharmaceutical requirements through their respective Pharmaceutical Prime Vendor (PPV) Programs. The purpose of this solicitation is to establish a supply source that will provide the drugs listed in the schedule for purchase through the PPV Programs. The total annual estimated usage for VA, Federal Health Care Center (FHCC), State Veterans Homes - Option 2 (SVH), DOD, Indian Health Service (IHS), and Bureau of Prisons (BOP) appears on the Schedule of Supplies section of this Solicitation. The objective of such a contract is to ensure availability and consistency of product for nationwide usage and to obtain volume-based, committed-use pricing.

Work Details
The specific products to be delivered under the contract are Clozapine Tablets. The contract requires one award to be made in the aggregate for line items 1, 2, 3, 4, and 5. Offerors must submit a price for the base year and all four one-year options for all line items. Prices offered shall not exceed two decimal places. Offered prices must include an 11 digit NDC number for each offered drug that is unique to the offeror's company as outlined in scope of contract. The delivery details including quantities, unit price, and amount are specified for each line item in the schedule of supplies.

Period of Performance
The Implementation Period begins on the Contract Effective Date and ends at the start of the Ordering Period. The base year Ordering Period will be in effect for one year.

Place of Performance
The products are to be delivered to various facilities/agencies including all Department of Veterans Affairs (VA) facilities, all Ordering Activities under the Department of Defense (DOD) Pharmaceutical Prime Vendor Program, all Indian Health Service (IHS) facilities, all Bureau of Prisons (BOP) facilities, Captain James A. Lovell Federal Health Care Center (FHCC), and all Option 2 State Veteran Homes.